Louis G Lange, Iii

This inventor holds 17 USPTO granted patents, primarily in Cholesterol Esterase Inhibition. Top assignees: Cv Therapeutics, Inc., Other. Active years: 1991-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis G Lange, Iii. Retrieved from https://idiyas.com/inventor/louis-g-lange-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 122(Granted Patents)

Location History:

St. Louis, MO (US) (1991 - 2000)
Portola Valley, CA (US) (1995 - 2006)

Company Filing History:

6 out of 105

Cv Therapeutics, Inc.

patents

11 out of 834,601

Other

patents

Years Active: 1991-2006

Loading Chart...

Areas of Expertise:

Cholesterol Esterase

Synthetic Polysaccharides

Pancreatic Lipids

Chemoattractant

RFLP Analysis

Peptides

Molecular Weight Fraction

Inhibitor

Human Absorption

Mammalian Enzymes

Sulfated Polysaccharides

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7071174 - Method and composition for inhibiting cholesterol esterase (2006-07-04),

2. 6632801 - Method and composition for inhibiting human cholesterol esterase (2003-10-14),

3. 6107026 - Methods and reagents for RFLP analysis of the human pancreatic (2000-08-22),

4. 5869537 - Macrophage lipid chemoattractant (1999-02-09),

5. 5792832 - Peptides from mammalian pancreatic cholesterol esterase (1998-08-11),

6. 5663450 - Macrophage lipid chemoattractant (1997-09-02),

7. 5624836 - DNA encoding bovine pancreatic cholesterol esterase (1997-04-29),

8. 5616570 - Use of non-absorbable synthetic sulfated polysaccharides to decrease (1997-04-01),

9. 5521303 - Method of manufacturing non-absorbable synthetic sulfated polysaccharides (1996-05-28),

10. 5492822 - Method for recovering purified 100,000 dalton molecular weight fraction (1996-02-20),

11. 5484777 - Pancreatic cholesterol esterase inhibitor (1996-01-16),

12. 5432058 - Method for measuring human cholesterol absorption using metabolically (1995-07-11),

13. 5429937 - Method for recovering purified 100,000 molecular weight fraction of (1995-07-04),

14. 5352601 - Method for recovering purified 52,000 dalton fraction of human (1994-10-04),

15. 5173408 - Mammalian pancreatic cholesterol esterase (1992-12-22),

Title: The Innovations of Louis G Lange, III

Introduction

Louis G Lange, III is a notable inventor based in St. Louis, MO. He holds a total of 17 patents that reflect his contributions to the field of medical science, particularly in cholesterol management. His work has significantly impacted the development of therapeutic methods aimed at lowering cholesterol levels in the bloodstream.

Latest Patents

Among his latest patents are two significant inventions. The first is a "Method and composition for inhibiting cholesterol esterase," which encompasses methods for manufacturing purified, high molecular weight sulfated polysaccharide compositions that inhibit pancreatic cholesterol esterase and lower cholesterol in the bloodstream. The second patent is titled "Method and composition for inhibiting human cholesterol esterase." This invention involves a method and composition for inhibiting human cholesterol absorption by ingesting a therapeutic amount of an inhibitor of human cholesterol esterase, comprising very high molecular weight sulfated polysaccharide with specific characteristics.

Career Highlights

Throughout his career, Louis G Lange, III has worked with various companies, including Cv Therapeutics, Inc. His innovative approaches have led to advancements in the medical field, particularly in cholesterol management.

Collaborations

Louis has collaborated with notable individuals such as Curtis A Spilburg and Paula M Kinnunen, contributing to the success of his projects and inventions.

Conclusion

Louis G Lange, III is a distinguished inventor whose work in cholesterol management has led to significant advancements in medical science. His patents and collaborations highlight his commitment to innovation and improving health outcomes.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]